David J. Mazzo
President & CEO, Director · LISATA THERAPEUTICS, INC.
Individual
- 2024
- Oct 2, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at David J. Mazzo's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $55.46M in COAG purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $51.68M in ELVN purchases and sales in the last 12 months
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David J. Mazzo?
David J. Mazzo is a corporate insider, tracked as President & CEO, Director of LISATA THERAPEUTICS, INC. (LSTA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David J. Mazzo last file a Form 4?
The only primary Form 4 on record is dated 2 October 2024.
